MDA-PCa-2bHomo sapiens (Human)Cancer cell line

Also known as: M.D. Anderson-Prostate Cancer-2b, MDA2B, MDAPC2B, MDAPCA2B, MDAPCa2b, MDAPCa-2b, MDA PCa 2b

🤖 AI SummaryBased on 7 publications

Quick Overview

Human prostate cancer cell line with androgen-sensitive properties.

Detailed Summary

MDA-PCa-2b is a human prostate cancer cell line derived from a bone metastasis of an African-American male. It is characterized as androgen-sensitive (AS), expressing the androgen receptor (AR) and androgen-responsive genes such as PSA. This cell line is commonly used in research to study prostate cancer biology, including mechanisms of androgen signaling, tumor progression, and drug response. Its androgen-sensitive nature makes it a valuable model for understanding the molecular pathways involved in prostate cancer development and for testing therapeutic strategies targeting androgen receptors. The cell line has been utilized in studies related to genetic ancestry, highlighting its importance in addressing health disparities in prostate cancer research.

Research Applications

Androgen signaling studiesProstate cancer biologyDrug response testingGenetic ancestry research

Key Characteristics

Androgen-sensitiveExpresses androgen receptor (AR)Derived from bone metastasisUsed in health disparities research
Generated on 6/21/2025

Basic Information

Database IDCVCL_4748
SpeciesHomo sapiens (Human)
Tissue SourceBone[UBERON:UBERON_0002481]

Donor Information

Age63
Age CategoryAdult
SexMale
Raceblack_or_african_american

Disease Information

DiseaseProstate carcinoma
LineageProstate
SubtypeProstate Adenocarcinoma
OncoTree CodePRAD

DepMap Information

Source TypeATCC
Source IDACH-000952_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,12
D13S317
11,12
D16S539
10,11
D18S51
16,17
D19S433
13.2,14.2,16
D21S11
33.2
D2S1338
22,24
D3S1358
14,17
D5S818
12,13
D7S820
8,10
D8S1179
14,15
FGA
20,21,22
Penta D
11,13
Penta E
8,14
TH01
8,9
TPOX
8,11
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines.

Mitra R., Nonn L., Kimbro K.S., Kittles R.A.

Cancer Epidemiol. Biomarkers Prev. 28:1003-1009(2019).

A novel approach for characterizing microsatellite instability in cancer cells.

Lu Y.-H., Soong T.D., Elemento O.

PLoS ONE 8:E63056-E63056(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.

Brooks J.D.

Prostate 63:187-197(2005).

Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines.

Nordeen S.K., Miller G.J., Varella-Garcia M.

Prostate 57:226-244(2003).

Molecular characterization of human prostate carcinoma cell lines.";

Smith E.E., Miller H.L., Nordeen S.K., Miller G.J., Lucia M.S.

Prostate 57:205-225(2003).

Human prostate cancer cell lines.";

Russell P.J., Kingsley E.A.

Methods Mol. Med. 81:21-39(2003).

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Logothetis C.J.

Clin. Cancer Res. 3:2493-2500(1997).